These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37436769)

  • 61. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.
    Horner JM; Kinoshita M; Webster TL; Haglund CM; Friedman PA; Ackerman MJ
    Heart Rhythm; 2010 Nov; 7(11):1616-22. PubMed ID: 20816872
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome.
    Earle N; Yeo Han D; Pilbrow A; Crawford J; Smith W; Shelling AN; Cameron V; Love DR; Skinner JR
    Heart Rhythm; 2014 Jan; 11(1):76-82. PubMed ID: 24096169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Diagnosis, sudden death risk stratification, and treatment of main long QT syndrome molecular-genetic variants].
    Shkol'nikova MA; Kharlap MS; Il'darova RA; Bereznitskaia VV; Kalinin LA
    Kardiologiia; 2011; 51(5):50-61. PubMed ID: 21649595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long QT syndrome in children.
    Zareba W; Moss AJ
    J Electrocardiol; 2001; 34 Suppl():167-71. PubMed ID: 11781951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical features and management of congenital long QT syndrome: a report on 54 patients from a national registry.
    Li C; Hu D; Qin X; Li Y; Li P; Liu W; Li Z; Li L; Wang L
    Heart Vessels; 2004 Jan; 19(1):38-42. PubMed ID: 14685754
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The long QT syndrome. Prospective longitudinal study of 328 families.
    Moss AJ; Schwartz PJ; Crampton RS; Tzivoni D; Locati EH; MacCluer J; Hall WJ; Weitkamp L; Vincent GM; Garson A
    Circulation; 1991 Sep; 84(3):1136-44. PubMed ID: 1884444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Congenital long QT syndromes: prevalence, pathophysiology and management.
    Barsheshet A; Dotsenko O; Goldenberg I
    Paediatr Drugs; 2014 Dec; 16(6):447-56. PubMed ID: 25288402
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan.
    Horigome H; Nagashima M; Sumitomo N; Yoshinaga M; Ushinohama H; Iwamoto M; Shiono J; Ichihashi K; Hasegawa S; Yoshikawa T; Matsunaga T; Goto H; Waki K; Arima M; Takasugi H; Tanaka Y; Tauchi N; Ikoma M; Inamura N; Takahashi H; Shimizu W; Horie M
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):10-7. PubMed ID: 19996378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.
    Mönnig G; Köbe J; Löher A; Eckardt L; Wedekind H; Scheld HH; Haverkamp W; Milberg P; Breithardt G; Schulze-Bahr E; Böcker D
    Heart Rhythm; 2005 May; 2(5):497-504. PubMed ID: 15840474
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-QT syndrome after age 40.
    Goldenberg I; Moss AJ; Bradley J; Polonsky S; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    Circulation; 2008 Apr; 117(17):2192-201. PubMed ID: 18427134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
    Mazzanti A; Kukavica D; Trancuccio A; Memmi M; Bloise R; Gambelli P; Marino M; Ortíz-Genga M; Morini M; Monteforte N; Giordano U; Keegan R; Tomasi L; Anastasakis A; Davis AM; Shimizu W; Blom NA; Santiago DJ; Napolitano C; Monserrat L; Priori SG
    JAMA Cardiol; 2022 May; 7(5):504-512. PubMed ID: 35353122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.
    Sundström E; Jensen SM; Diamant UB; Rydberg A
    Scand Cardiovasc J; 2017 Apr; 51(2):88-94. PubMed ID: 27936942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome.
    Noda T; Takaki H; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Kamakura S; Sunagawa K; Nakamura K; Ohe T; Horie M; Napolitano C; Towbin JA; Priori SG; Shimizu W
    Eur Heart J; 2002 Jun; 23(12):975-83. PubMed ID: 12069453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome.
    Shimizu W; Tanabe Y; Aiba T; Inagaki M; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Sunagawa K; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(12):1984-91. PubMed ID: 12084597
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long QT syndrome and pregnancy.
    Seth R; Moss AJ; McNitt S; Zareba W; Andrews ML; Qi M; Robinson JL; Goldenberg I; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    J Am Coll Cardiol; 2007 Mar; 49(10):1092-8. PubMed ID: 17349890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group.
    Rosero SZ; Zareba W; Moss AJ; Robinson JL; Hajj Ali RH; Locati EH; Benhorin J; Andrews ML
    Am J Cardiol; 1999 Dec; 84(12):1406-11. PubMed ID: 10606113
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of phenylephrine provocation on dispersion of repolarization in congenital long QT syndrome.
    Khositseth A; Nemec J; Hejlik J; Shen WK; Ackerman MJ
    Ann Noninvasive Electrocardiol; 2003 Jul; 8(3):208-14. PubMed ID: 14510655
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
    Shimizu W; Aiba T; Antzelevitch C
    Curr Pharm Des; 2005; 11(12):1561-72. PubMed ID: 15892662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
    Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ
    Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study.
    Itoh H; Shimizu W; Hayashi K; Yamagata K; Sakaguchi T; Ohno S; Makiyama T; Akao M; Ai T; Noda T; Miyazaki A; Miyamoto Y; Yamagishi M; Kamakura S; Horie M
    Heart Rhythm; 2010 Oct; 7(10):1411-8. PubMed ID: 20541041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.